Infectious Diseases

Anti-Covid treatments being given to Trump are still unproven, say experts

  • by

Neither remdesivir nor REGN-COV2 have completed large-scale randomised trials, say UK scientists Coronavirus – latest updates See all our coronavirus coverage Scientists still lack conclusive proof that the two anti-Covid drugs given to Donald Trump are clinically effective. UK researchers point out that both medicines… Read More »Anti-Covid treatments being given to Trump are still unproven, say experts

Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes

  • by

Healthcare workers and health departments will be among the first to use the rapid antigen tests Full Australian Covid stats; Covid restrictions state by state Follow our global live blog Vic cases map; NSW cases map NSW hotspots list; Qld hotspots list Australia’s drugs regulator… Read More »Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes

Monoclonal Antibody Data

  • by

We have a bit of human clinical data from the Eli Lilly/Abcellera collaboration to make a monoclonal antibody therapy against the coronavirus. A full paper is coming soon, the press release says, but for now it looks like this is all we have to go… Read More »Monoclonal Antibody Data

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

  • by

Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot,… Read More »Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant

  • by

A spokesman for AstraZeneca, the company working on the coronavirus vaccine, said pausing trials was common during vaccine development The development of a promising Covid-19 vaccine has been put on hold due to a possible adverse reaction in a trial participant. A spokesman for AstraZeneca,… Read More »Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant

The Russian Vaccine

  • by

Many will have heard Russia’s announcement that they have approved a coronavirus vaccine. I’ve already had several people ask me what I think of it, so let me be clear: I think it’s a ridiculous publicity stunt. If it’s supposed to make Russia look like… Read More »The Russian Vaccine

Vaccine Data From Novavax

  • by

Several days after making some headlines with a press release about the data, the Novavax vaccine effort has published on Medrxiv. The is the first look at human data we have at an approach using recombinant coronavirus proteins (plus an adjuvant, in this case a… Read More »Vaccine Data From Novavax

The world needs a ‘people’s vaccine’ for coronavirus, not a big-pharma monopoly | Helen Clark and Winnie Byanyima

  • by

AstraZeneca and others should not own a lucrative patent on a medicine that is needed by poor as well as rich nations • See all our coronavirus coverage • Helen Clark is a former prime minister of New Zealand and Winnie Byanyima is UN undersecretary… Read More »The world needs a ‘people’s vaccine’ for coronavirus, not a big-pharma monopoly | Helen Clark and Winnie Byanyima

Bacteria and Colon Cancer

  • by

Let’s catch on some non-coronavirus research today with an interesting approach against a very bad disease, metastatic colon cancer. This new paper (from groups at Virginia Tech and Wake Forest) adds to our understanding of something that’s been noticed for some time: colon cancer tissue… Read More »Bacteria and Colon Cancer

New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19

  • by

Throughout history, infectious diseases caused by pathogens such as bacteria or viruses have taken a devastating toll on the lives and security of people around the world. With the ongoing COVID-19 pandemic gripping the world, we are experiencing a challenging situation that we haven’t seen… Read More »New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19

Moderna’s Phase I Data

  • by

Well, it’s finally here – eight weeks to the day after press-releasing some top line results, the full paper is out on the Moderna mRNA vaccine candidate’s Phase I trial. I’m very glad to see it – it’s going to be very important for the… Read More »Moderna’s Phase I Data

Pfizer’s Progress

  • by

I wanted to point out an interesting interview given by Pfizer’s CEO Albert Bourla to Time. I have made some pointed remarks about Pfizer over the years, but this is one of the better Q&A pieces like this that I have seen – you’ll see… Read More »Pfizer’s Progress

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital Coronavirus – latest updates See all our coronavirus coverage The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients… Read More »

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

  • by

Richard Horton does not hold back in his criticism of the UK’s response to the pandemic and the medical establishment’s part in backing fatal government decisions Coronavirus – latest updates See all our coronavirus coverage There is a school of thought that says now is… Read More »

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’